MACOP-B化疗用于治疗HIV-1感染患者的高级别淋巴瘤。
MACOP-B chemotherapy for the treatment of high-grade lymphomas in patients with HIV-1 infection.
作者信息
Taillan B, Garnier G, Ferrari E, Pesce A, Vinti H, Fuzibet J G, Dujardin P
机构信息
Department of Internal Medicine, Cimiez Hospital, Nice, France.
出版信息
Acta Haematol. 1993;89(1):10-2. doi: 10.1159/000204475.
PMID:7683165
Abstract
Recent studies showed that patients with non-Hodgkin's lymphoma (NHL) with human immunodeficiency virus type 1 (HIV-1) infection may benefit from an intensive chemotherapeutic regimen. We report on our experience in the treatment of NHL-associated HIV-1 infection, with excellent prognostic factors, with MACOP-B regimen.
摘要
近期研究表明，感染人类免疫缺陷病毒1型（HIV-1）的非霍奇金淋巴瘤（NHL）患者可能从强化化疗方案中获益。我们报告了采用MACOP-B方案治疗伴有HIV-1感染且具有良好预后因素的NHL的经验。
Zotero 插件